News | January 29, 2014 Nuke Imaging Tools Tested to Understand Effects of Concussions News | Radiopharmaceuticals and Tracers | July 16, 2019 NorthStar Medical Radioisotopes Completes Construction on Beloit, Wis. Molybdenum-99 Processing Facility NorthStar Medical Radioisotopes LLC announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-… read more News | Radiopharmaceuticals and Tracers | July 26, 2019 NorthStar Medical Radioisotopes Awarded $30 Million by U.S. Department of Energy NorthStar Medical Radioisotopes LLC has been awarded $15 million in a cooperative agreement with the U.S. Department of… read more The researchers used S.P.E.C.T. to track cerebral blood flow (C.B.F.), movement of blood through the brain and neurotransmitter dopamine by tracking the binding of a dopamine transporter (D.A.T.) tracer. News | Radiopharmaceuticals and Tracers | August 02, 2019 ASRT Supports Radiopharmaceutical Reimbursement Bill The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) 3772, a measure… read more News | Magnetic Resonance Imaging (MRI) | June 07, 2019 Amsterdam University Medical Center Wins MR Solutions’ Image of the Year Award The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular… read more Related Content News | PET-CT | August 15, 2019 United Imaging Announces First U.S. Clinical Installation of uExplorer Total-body PET/CT United Imaging announced that its uExplorer total-body positron emission tomography/computed tomography (PET/CT) system… read more For more information: www.jefferson.edu FacebookTwitterLinkedInPrint分享 Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers. News | Radiopharmaceuticals and Tracers | July 01, 2019 Bracco Imaging Acquires Blue Earth Diagnostics Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company… read more T.B.I. patients were discovered to have an average of six brain regions with abnormal perfusion, while controls had an average of two abnormal regions (P<0.0001). Patients with headaches had lower C.B.F. in the right frontal lobe and higher C.B.F. in the left parietal lobe compared to patients without headaches. Lower C.B.F. in the right temporal lobe correlated with poorer reported physical health. Higher D.A.T. binding was associated with more depressive symptoms and overall poorer reported mental health. However, there was no clear association between C.B.F. and D.A.T. binding in the patients studied. News | Computed Tomography (CT) | June 17, 2019 International Working Group Releases New Multiple Myeloma Imaging Guidelines An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for... read more Researchers concluded that S.P.E.C.T. imaging of D.A.T. and C.B.F. were useful tools that provide distinct information about brain physiology after T.B.I. News | PET-CT | June 19, 2019 United Imaging Announces First U.S. Clinical Install of uMI 550 Digital PET/CT United Imaging announced the first U.S. clinical installation of the uMI 550 Digital positron emission tomography/... read more January 29, 2014 — Researchers are seeking to understand what happens inside the living brain after a concussion. In a study published today in PLOS ONE, researchers at Thomas Jefferson University used single photon emission computed tomography (S.P.E.C.T.) to evaluate two ways to measure physiological brain activity in Traumatic Brain Injury (T.B.I.) patients with chronic, mild symptoms. The findings of their blinded, case-control study are published in an article entitled, Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury. The study included 25 cases and 10 controls. Technology | Information Technology | June 20, 2019 DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet... read more News | Interventional Radiology | July 31, 2019 International Multidisciplinary Group Publishes Recommendations for Personalized HCC Treatment With Y90 TheraSphere New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have... read more X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.